Literature DB >> 9872821

Measurements of exhaled nitric oxide with the single-breath technique and positive expiratory pressure in infants.

J H Wildhaber1, G L Hall, S M Stick.   

Abstract

The aim of this study was to adapt the single-breath technique with positive expiratory pressure to measure exhaled nitric oxide (eNO) in infants. We hypothesized that exhaled eNO was greater in wheezy than in healthy infants. We studied 30 infants (16 wheezy and 14 healthy). The forced expiratory volume in 0.5 s (FEV0.5) was determined with the raised volume rapid thoracic compression technique, and eNO was measured during constant expiratory flow with a rapid-response chemiluminescence analyzer. After passive inflation to a preset pressure of 20 cm H2O, thoracic compression with an inflatable jacket caused forced expiration to occur through a face-mask with an expiratory flow resistor attached. During the forced expiration, the jacket pressure was increased to maintain a constant driving mouth pressure and hence a constant expiratory flow (50 ml/s). The mean level of eNO in the wheezy infants (31.8 ppb) was significantly higher than the level in healthy infants (18.8 ppb) (p = 0.03). A family history of atopy in parents was associated with increased eNO levels (p < 0.001) independent of age, sex, weight, length, wheezing, and FEV0.5. We conclude that the single-breath technique with positive expiratory pressure is a feasible method for measuring eNO in infants. Levels of eNO were significantly higher in wheezy infants and in those with a family history of atopy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9872821     DOI: 10.1164/ajrccm.159.1.9805021

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

Review 1.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

2.  Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers.

Authors:  Jason S Debley; David C Stamey; Elizabeth S Cochrane; Kim L Gama; Gregory J Redding
Journal:  J Allergy Clin Immunol       Date:  2010-05-11       Impact factor: 10.793

3.  Expired nitric oxide and airway reactivity in infants at risk for asthma.

Authors:  Robert S Tepper; Conrado J Llapur; Marcus H Jones; Christina Tiller; Cathy Coates; Risa Kimmel; Jeffrey Kisling; Barry Katz; Yan Ding; Nancy Swigonski
Journal:  J Allergy Clin Immunol       Date:  2008-08-28       Impact factor: 10.793

4.  Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants and toddlers.

Authors:  M Elliott; S L Heltshe; D C Stamey; E S Cochrane; G J Redding; J S Debley
Journal:  Clin Exp Allergy       Date:  2013-12       Impact factor: 5.018

5.  Assessment of airway inflammation with exhaled NO measurement.

Authors:  E Hatziagorou; J Tsanakas
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

6.  Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children.

Authors:  P J Franklin; S W Turner; P N Le Souëf; S M Stick
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

Review 7.  The Role of FeNO in Predicting Asthma.

Authors:  Mariëlle W Pijnenburg
Journal:  Front Pediatr       Date:  2019-02-21       Impact factor: 3.418

Review 8.  Role of epithelial nitric oxide in airway viral infection.

Authors:  Weiling Xu; Shuo Zheng; Raed A Dweik; Serpil C Erzurum
Journal:  Free Radic Biol Med       Date:  2006-02-20       Impact factor: 7.376

9.  Exhaled Nitric Oxide in Wheezy Infants Predicts Persistent Atopic Asthma and Exacerbations at School Age.

Authors:  Maria P White; Tessa K Kolstad; Molly Elliott; Elizabeth S Cochrane; David C Stamey; Jason S Debley
Journal:  J Asthma Allergy       Date:  2020-01-07

10.  Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications.

Authors:  Carmelo Gabriele; Fernando M de Benedictis; Johan C de Jongste
Journal:  Ital J Pediatr       Date:  2009-07-20       Impact factor: 2.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.